Abstract
purpose. To determine whether age-related changes in Bruch’s membrane affect
its permeability to macromolecules. Such changes have been postulated
to underlie some pathologic manifestations of age-related macular
degeneration.
methods. Bruch’s membrane preparations were isolated from the macular region of
donated human eyes of differing age and mounted in a modified Ussing
chamber. Permeability to macromolecules was assessed by simultaneously
placing a physiological concentration of serum proteins adjacent to the
choroidal margin of the membrane preparation and a saline solution
adjacent to the retinal pigment epithelial basement membrane. After 24
hours, the protein content of the saline solution was measured by
standard assay and permeability calculated as the quantity of protein
traversing the membrane preparation per unit area. The spectrum of
proteins able to cross the membrane was assessed by subjecting the
diffusate proteins to electrophoretic separation and the resultant gel
to scanning densitometry.
results. The permeability of Bruch’s membrane to serum proteins decreased
10-fold from the first to the ninth decade of life, and on regression
analysis this decline exhibited a linear relationship with donor age
(P < 0.0005). Membrane preparations from young
donors were permeable to proteins with a molecular weight in excess of
200 kDa, but with increasing age, the membrane progressively impeded
the passage of high-molecular-weight entities. Even so, elderly
membranes were still permeable to macromolecules with molecular weights
in excess of 100 kDa. Results from the oldest preparation studied
suggest that by the ninth decade, the membrane may selectively impede
the flux of specific proteins, based on a criterion other than
molecular weight.
conclusions. The results imply that, with increasing age, the capacity of Bruch’s
membrane to facilitate macromolecular exchange between the choroidal
and the retinal pigment epithelial compartments is
reduced.
Age-related macular degeneration (ARMD) is the leading
cause of irreversible blindness in Europe, North America, and other
industrialized regions.
1 2 3 Evidence suggests that the
pathologic manifestations of ARMD are the end stage of a lifelong
continuum of change, influenced by both genetic predisposition and
environmental factors, and focused at the level of Bruch’s
membrane.
4 5 6 7 The study of age-related changes are likely
to be helpful in understanding ARMD. Morphologic and biochemical
studies have demonstrated considerable senescent alteration to Bruch’s
membrane, typified by increased thickness and the progressive
accumulation of deposits within the inner layers. A number of
hypotheses, each with appropriate supporting evidence, have been
proposed to explain these changes. These may not be mutually exclusive
and include altered remodeling of the membrane, an immune response,
dysfunctional choriocapillary endothelium and the deposition of
incompletely digested waste material emanating from a dysfunctional
retinal pigment epithelium (RPE).
8 9 10 It has been
suggested that changes to Bruch’s membrane progressively impede the
net outflow of water from the retina and metabolic exchange between the
choriocapillaris and the RPE.
4 11 12 We, and others, have
demonstrated a senescent decline in the hydraulic conductivity
(permeability) of both macular and peripheral Bruch’s
membrane.
13 14 In addition, we have ascertained that the
presence of lipid deposits plays a small, yet statistically
significant, role in this reduction in hydraulic
conductivity.
14 These findings have been confirmed by
others.
15 Lipids are but one component of the complex
composition of deposits found in Bruch’s membrane. Other components
include collagens, adhesion molecules, lipoproteins, and advanced
glycosylated end products.
4 5 6 8 10
The effects of senescence on metabolic flux across Bruch’s membrane
have yet to be ascertained. However, evidence from two groups of
studies suggests that macromolecular flux may be impaired with
increasing age. First, fluorescein angiography has revealed that
elderly patients with good visual acuity may have areas of the fundus
that exhibit delayed choroidal perfusion.
16 Functional
assessment showed that such areas exhibit elevated dark adaptation
thresholds and a pattern of change similar to that observed in vitamin
A deficiency.
17 18 Second, similar findings were found in
mildly affected persons with the inherited disease Sorsby fundus
dystrophy.
19 This disease is typified by midlife onset of
loss of central vision, subretinal disease with similarities to ARMD,
and the presence of a 30-μm thick lipid-rich deposit within Bruch’s
membrane.
20 21 The conclusion from both sets of studies
was that functional loss is due to diffuse deposits in Bruch’s
membrane that act as a barrier to metabolic exchange.
This concept has been further supported by clinical trials that have
demonstrated that dietary supplementation with vitamin A can reverse
the elevation in scotopic thresholds in the early stages of Sorsby
fundus dystrophy.
22 It is assumed that this occurs by
raising the systemic concentration of vitamin A and thus the gradient
that drives flux, leading to an increase in vitamin A transport across
Bruch’s membrane and improvement in photoreceptor function.
Unfortunately, the high doses of vitamin A required to alleviate
blindness in these studies were too toxic for long-term use. Vitamin A
(retinol) moves across Bruch’s membrane bound to a carrier,
retinoid-binding protein (RBP), and an associated protein,
transthyretin.
23 This complex has a combined molecular
weight of 75 kDa. Therefore, for good vision to be maintained, Bruch’s
membrane has to be readily permeable to entities of considerable mass
and size. There is no information on the macromolecular permeability of
human Bruch’s membrane or its variation throughout life.
Using human serum as a tracer, the purpose of this study was to measure
the macromolecular permeability of human macular Bruch’s membrane, the
magnitude of the molecular weight limit imposed on macromolecular
transport, and the effect of age on these parameters.
This is the first study to measure the permeability of human
Bruch’s membrane to macromolecules,
25 the first to
attempt to determine the size exclusion limit of the membrane, and the
first to ascertain the effects of senescence on the barrier the
membrane presents to the flux of entities other than water.
There are a number of important areas regarding the method used in this
study that warrant discussion. The number of specimens used in this
study could be considered small; however, it is in keeping with other
studies measuring permeability of human Bruch’s
membrane.
13 14 26 27 The primary reasons for these
limitations were a lack of donor eyes for which research permission had
been given by the next of kin, competition for donor material from
other studies, and the duration of each measure of permeability. With
prior knowledge of these limitations, we did not set out to investigate
topographical or bilateral variation in macromolecular permeability, or
to correlate histologic features with permeability. These areas still
require investigation.
A criticism of this study is that we used a Bruch’s membrane
preparation that contained an adherent portion of the underlying
choroid. Since we first reported the isolation of such a preparation
and discussed its relative merits,
13 it has become the
standard for use when measuring the hydraulic permeability of Bruch’s
membrane.
13 14 15 26 27 In our experience, attempts to
remove choroidal elements result in deformation and damage to Bruch’s
membrane, rendering it unfit for further study. The attached choroid
can be viewed as two components, the choriocapillaris and the stroma,
with both having different effects on permeability. First, the border
between the choriocapillaris and the outer limit of Bruch’s membrane
is difficult to define, because the outer collagenous layer extends to
form the intercapillary columns of the choriocapillaris. Similar to
Bruch’s membrane, these columns undergo age-related alteration,
becoming broader and accumulating deposits.
28 29 As such,
they may also influence metabolic exchange between the choroid and RPE.
Second, extending from the choriocapillaris to the outer edge of the
preparation was a large portion of stroma. Hydraulic conductivity
studies have demonstrated that the barrier presented by this stromal
component is infinitesimal when compared with that of Bruch’s
membrane.
26
Our previous studies suggest that the total thickness of isolated
membrane preparations decreases with increasing age, primarily because
of age-related choroidal atrophy within the stroma.
30 If
such a trend were to have a biophysical effect it would be to increase
permeability, and it therefore cannot explain the age-related decrease
in the macromolecular permeability observed in the present study. The
only effect of the stromal component of preparations would be to mask
an even greater senescent decline in permeability. Therefore, the
senescent decrease in macromolecular permeability must result from
alteration to factors intrinsic to Bruch’s membrane.
In planning this study, we assumed that some of the serum protein
molecules might be too large to traverse the membrane. Therefore, there
was a need to reduce any osmotic fluid movement that could have
resulted in the development of a hydrostatic gradient and a reduction
in the concentration gradient across the tissue. We attempted to lessen
the osmotic potential by placing a sodium chloride solution of equal
osmolarity to the serum in the adjacent compartment of the modified
Ussing chamber. Theoretically, this approach is flawed, in that the
diffusion coefficient of
Na+Cl− in both free
solution and Bruch’s membrane would be expected to be greater than
that of any given protein component of serum. Thus the
Na+Cl− would more rapidly
distribute between the compartments and would not act to reduce the
development of a hydrostatic gradient or of a reduction in the serum
concentration gradient. However, we observed no differential in the
volume of fluid between the Ussing chamber compartments after a 24-hour
incubation period. In pilot studies in which water was used instead of
a sodium chloride solution, an increase in volume of approximately 10%
to 15% was measured in the serum compartment over the same incubation
period. Thus, the sodium chloride solution substantially neutralized
the development of a hydrostatic gradient.
The electrophoretic separation of diffusate protein was undertaken
using a denaturing buffer system, and therefore the actual molecular
weight of proteins capable of traversing Bruch’s membrane may be
greater than those measured in this study.
We possessed minimal clinical information about the donors, and it is
possible that some donors had diseases or had undergone treatments that
influenced our results. However, macroscopic examination during
dissection did not identify any eyes with features of overt senescence,
other disease, or laser treatment. Combined with the consistency of the
data, this indicates that the results represent the normal aging
profile of the macromolecular permeability of Bruch’s membrane.
Our results indicate that senescence has three effects on the
membrane’s macromolecular permeability. First, with increasing age,
the membrane progressively impedes the flux of all macromolecules.
Second, the molecular weight exclusion limit of the membrane gradually
reduces with age, with the large macromolecules that were able to pass
through the membrane in youth being excluded or restricted in old age.
Third, by the ninth decade the membrane may selectively impede the
passage of specific macromolecules, with this restriction based on
criteria other than molecular weight.
This senescent decline in permeability lends considerable support to
the current hypothesis of the ageing Bruch’s membrane’s presenting an
increasing barrier to metabolic exchange between the choriocapillaris
and the RPE.
4 11 12 A recent pilot study using similar
methods also supports this concept.
31 The decline in
permeability, in the absence of obvious disease, indicates either that
there is a large excess capacity for flux within Bruch’s membrane
and/or that there is a tolerance to reduced flux in adjacent tissues.
However, a permeability threshold can be envisaged below which rates of
metabolic exchange become limiting for maintenance of the overlying
retina, which may contribute to pathologic manifestations of outer
retinal senescence. An investigation comparing the permeability of the
membrane from eyes with and without early signs of ARMD would be useful
in this respect.
The current experimental procedures did not allow precise determination
of the size-exclusion limit of the membrane preparations. However, we
were able to ascertain that this limit was greater than 200 kDa in the
young and reduced to between 100 and 200 kDa in the elderly. A barrier
of this magnitude would be insufficient to exclude the vitamin
A-RBP-transthyretin complex. However, the discovery of
choriocapillary-derived fibrinogen (340 kDa) and compliment components
C
1q (400 kDa) and C
3c (≈185 kDa) at the outer limit of the outer collagenous layer support
our findings of Bruch’s membrane as a barrier to larger
macromolecules.
32
Assessment of the physiological impact of a decline in the size
exclusion limit of the membrane is limited. One approach would be to
draw comparisons with the exclusion limits of the routes of flux across
the choriocapillary endothelium. Unfortunately, most studies on the
latter have been undertaken on animal models, and the application of
findings to the present human study is precluded by species variation
in ocular architecture and the resultant differing metabolic demands of
the retinas.
33 34 35 36 37
The mechanism that brings about a reduction in permeability is unknown.
That the decline appears to begin early in life before major
accumulation of deposits within the membrane suggests that a
combination of factors are involved. For the most part permeability
depends on the thickness and the porosity of the membrane, dictated by
the state of the fibers, the interfiber matrix, and the deposition of
lipid-rich debris. Any mechanism acting to alter one or more of these
components could alter permeability. A combination of mechanisms is
envisaged. For example, altered remodeling of the membrane could reduce
porosity, leading to a decrease in permeability, precipitating the
deposition of debris, which further decreases permeability. Support for
such concepts comes from a recent pilot study in which reduced
dimensions of pores were reported in the fibrous layers of elderly
membranes.
38
The specific restriction by an elderly membrane of one macromolecule
compared with another of similar molecular weight could be due to a
combination of two factors. First, the restricted protein may possess a
more globular structure giving it greater dimensions and the inability
to pass through narrowed flux routes. Second, selectivity may occur
based on the electrostatic charge carried by the molecule and the
membrane at physiological pH. Similar to all basement membrane systems,
Bruch’s membrane is rich in proteoglycans, the glycosaminoglycan
moieties of which are some of the most highly negatively charged
molecules in the body and have been shown to endow extracellular
matrices with selective filtration properties.
39 40 41 Alteration in glycosaminoglycan content has been shown to change the
macromolecular permeability of extracellular matrices.
41 No study has directly assessed senescent variation in the proteoglycan
content of Bruch’s membrane. However, it has been determined that
glycosaminoglycans are synthesized in the same ratio throughout life,
but after the age of 70 there is an increase in the molecular weight of
proteoglycans in Bruch’s membrane.
42 Alteration in
proteoglycan content and structure may give rise to a change in the
charge selectivity of the membrane and differential exclusion of
molecules in the elderly membrane, as observed in this study.
From the vitamin A supplementation studies in persons with scotopic
threshold defects due to Sorsby fundus dystrophy, we know that it is
possible to overcome presumed flux inhibition by Bruch’s membrane and
reverse visual function loss. For supplementation to be a viable
therapy, a diet rich in or supplemented with all the metabolites needed
by the outer retina would be required. Unfortunately, the spectrum of
metabolites remains unknown. Another strategy would be to elevate
permeability by removing the barrier within the membrane. Pilot studies
on the feasibility of such an approach are needed.
Pilot studies for this research were undertaken by DJM as part of the
study for a PhD degree (under the supervision of John Marshall) at the
United Medical and Dental Schools, University of London, UK,
1992–1996.
Supported by The Auckland Medical Research Foundation, The New Zealand
Lottery Grants Board Health Grant 53544, and The New Zealand National
Eye Bank.
Submitted for publication September 11, 2000; revised March 23, 2001;
accepted April 6, 2001.
Commercial relationships policy: N.
The publication costs of this article were defrayed in part by page
charge payment. This article must therefore be marked“
advertisement” in accordance with 18 U.S.C. §1734
solely to indicate this fact.
Corresponding author: David J. Moore, Department of Public Health and
Epidemiology, University of Birmingham, Birmingham B15 2TT, UK.
[email protected]
The authors thank the Transplant Coordinators Margaret Small,
Rosalie Gow, and Jayne Chaulk for invaluable assistance in obtaining
donor material and Nigel Brookes and Steve Edgar for supplying
technical assistance.
Evans J. Causes of blindness and partial sight in England and Wales.
Studies on Medical and Population Subjects. No. 57. London:
Her Majesty’s Stationary Office; 1995:1990–1991.
Klein R, Klein BEK, Linton KLP. Prevalence of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology
. 1992;99:933–943.
[CrossRef] [PubMed]Mitchell P, Smith W, Attebo K, Wang JJ. The prevalence of age-related maculopathy in Australia: The Blue Mountains Eye Study. Ophthalmology
. 1995;102:1450–1460.
[CrossRef] [PubMed]Sarks SH. Aging and degeneration in the macular region: a clinico-pathological study. Br J Ophthalmol
. 1976;60:324–341.
[CrossRef] [PubMed]Feeney-Burns L, Ellersieck MR. Age related changes in the ultrastructure of Bruch’s membrane. Am J Ophthalmol
. 1985;100:686–697.
[CrossRef] [PubMed]Green WR, Enger C. The 1992 Lorenz E Zimmerman Lecture. Age related macular degeneration histopathologic studies. Ophthalmology
. 1993;100:1519–1535.
[CrossRef] [PubMed]Ramrattan RS, van der Schaft TL, Mooy CM, de Bruijn WC, Mulder PGH, de Jong PTVM. Morphometric analysis of Bruch’s membrane, the choriocapillaris and the choroid in aging. Invest Ophthalmol Vis Sci
. 1994;35:2857–2864.
[PubMed]Marshall J, Hussain AA, Starita C, Moore DJ, Patmore AL. Aging and Bruch’s membrane. Marmor MF Wolfensberger TJ eds. The Retinal Pigment Epithelium. 1998;669–692. Oxford University Press Oxford.
Johnson LV, Staples MK, Nealon MR, Anderson DH. Age-related maculopathy: immune complex pathogenesis in drusen formation. Invest Ophthalmol Vis Sci. 2000;41(4)S24.Abstract nr 121
Karwatowski WSS, Jefferies TE, Duance VC, Albon J, Bailey AJ, Easty DL. Preparation of Bruch’s membrane and analysis of age-related changes in the structural collagens. Br J Ophthalmol
. 1995;79:944–952.
[CrossRef] [PubMed]Bird AC, Marshall J. Retinal pigment epithelial detachments in the elderly. Trans Soc Ophthalmol UK. 1986;105:674–682.
Grindle CFJ, Marshall J. Aging changes in Bruch’s membrane and their functional implications. Trans Soc Ophthalmol UK. 1978;98:172–175.
Moore D, Hussain AA, Marshall J. Age-related variation in the hydraulic conductivity of Bruch’s membrane. Invest Ophthalmol Vis Sci
. 1995;36:1290–1297.
[PubMed]Moore DJ, Clover GM. The effect of extracting lipid deposits on the
hydraulic conductivity of Bruch’s membrane. Invest
Ophthalmol Vis Sci. In press.
Hodgetts A, Hussain AA, Marshall J. Effect of enzymatic modulation on the hydrodynamics of ageing human Bruch’s membrane [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1998;39(4)S369.Abstract nr 1724
Pauleikhoff D, Chen J, Chisholm I, Bird AC. Choroidal perfusion abnormality with age related Bruch’s membrane change. Am J Ophthalmol
. 1990;109:211–217.
[CrossRef] [PubMed]Chen J, Fitzke F, Pauleikhoff D, Bird A. Functional loss in age related Bruch’s membrane change with a choroidal perfusion defect. Invest Ophthalmol Vis Sci
. 1992;33:334–340.
[PubMed]Steinmetz RL, Haimovichi R, Jubb C, Fitzke RW, Bird AC. Symptomatic abnormalities of dark adaptation in patients with age related Bruch’s membrane change. Br J Ophthalmol
. 1993;77:549–554.
[CrossRef] [PubMed]Steinmetz RL, Polkinghorne PC, Fitzke FW, Kemp CM, Bird AC. Abnormal dark adaptation and rhodopsin kinetics in Sorsby’s fundus dystrophy. Invest Ophthalmol Vis Sci
. 1992;33:1633–1636.
[PubMed]Sorsby A, Mason MEJ, Gardener N. A fundus dystrophy with unusual features. Br J Ophthalmol
. 1949;33:67–97.
[CrossRef] [PubMed]Capon MR, Marshall J, Kraft J, Alexander RA, Hiscott PS, Bird AC. Sorsby’s fundus dystrophy: a light and electron microscopic study. Ophthalmology
. 1989;96:1769–1777.
[CrossRef] [PubMed]Jacobson SG, Cideciyan AV, Regunath G, et al. Night blindness in Sorsby’s fundus dystrophy reversed by vitamin A. Nat Genet
. 1995;11:27–32.
[CrossRef] [PubMed]Bok D. Retinal photoreceptor-pigment epithelium interactions. Friedenwald Lecture. Invest Ophthalmol Vis Sci
. 1985;26:1659–1694.
[PubMed]Laemmli VK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature
. 1970;227:680–685.
[CrossRef] [PubMed]Moore DJ, Hussain AA, Marshall J. Senescent reduction in the macromolecular permeability of Bruch’s membrane [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1997;38(4)S353.Abstract nr 1647
Starita C, Hussain AA, Patmore A, Marshall J. Localisation of the site of major resistance to fluid transport in Bruch’s membrane. Invest Ophthalmol Vis Sci
. 1997;38:762–767.
[PubMed]Starita C, Hussain AA, Pagliarini S, Marshall J. Hydrodynamics of ageing Bruch’s membrane: implications for macular disease. Exp Eye Res
. 1996;62:565–572.
[CrossRef] [PubMed]Pauleikhoff D, Harper CA, Marshall J, Bird AC. Aging changes in Bruch’s membrane: a histochemical and morphological study. Ophthalmology
. 1990;97:171–178.
[PubMed]Olver J, Pauleikhoff D, Bird AC. Morphometric analysis of age changes in the choriocapillaris [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1990;31(4)S229.Abstract nr 47
Moore D. An investigation of the permeability of Bruch’s membrane and its variation with age. 1996; University of London Library. Doctoral thesis London.
Hussain AA, Starita C, Marshall J. Molecular weight size exclusion limit and diffusional status of aging human Bruch’s membrane [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1999;40(4)S920.Abstract nr 4852
van der Schaft TL, Mooy CM, de Bruijn WC, de Jong PT. Early stages of AMD an immunofluorescence and electron microscopic study. Br J Ophthalmol
. 1993;77:657–661.
[CrossRef] [PubMed]Bernstein MH, Hollenberg MJ. Fine structure of the choriocapillaris and the retinal capillaries. Invest Ophthalmol
. 1965;4:1016–1025.
[PubMed]Okuma M, Uyama M. Electron microscopic studies of permeability of the choroidal vessels. I: ferritin transfer across the choriocapillary wall. Acta Soc Ophthalmol Jpn. 1972;76:323–330.
Pino RM, Essner E. Permeability of the rat choriocapillaris to haeme proteins: restriction of tracers by a fenestrated endothelium. J Histochem Cytochem
. 1981;29:281–290.
[CrossRef] [PubMed]Pino RM, Thuron CC. Vascular permeability in the rat eye to endogenous albumin and IgG examined by immunohistochemical methods. J Histochem Cytochem
. 1983;31:411–416.
[CrossRef] [PubMed]Pino RM. Restriction of endogenous plasma proteins by a fenestrated capillary endothelium: an ultrastructural immunocytochemical study of choriocapillary endothelium. Am J Anat
. 1985;172:279–289.
[CrossRef] [PubMed]Hussain AA, Starita C, Patmore A, Marshall J. Ultrastructural evaluation of porosity of individual layers of Bruch’s membrane and correlation with the rate limiting site for fluid transport [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1997;38(4)S353.Abstract nr 1648
Pino RM, Essner , Pino LC. Localisation and chemical composition of anionic sites in Bruch’s membrane of the rat. J Histochem Cytochem
. 1982;30:245–252.
[CrossRef] [PubMed]Call T, Hollyfield J. Sulphated proteoglycans in Bruch’s membrane of the human eye: localisation and characterisation using cupromeronic blue. Exp Eye Res
. 1990;51:451–462.
[CrossRef] [PubMed]Kanwar YS, Linker A, Farquar MG. Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulphate) by enzyme digestion. J Cell Biol
. 1980;86:688–693.
[CrossRef] [PubMed]Hewitt AT, Nakazawa K, Newsome DA. Analysis of newly synthesized Bruch’s membrane proteoglycans. Invest Ophthalmol Vis Sci
. 1989;30:478–486.
[PubMed]